Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
AK Medical Holdings Ltd. ( (HK:1789) ) has shared an update.
AK Medical Holdings Ltd. announced its unaudited consolidated interim results for the first half of 2025, reporting a 5.6% increase in revenue to approximately RMB694.2 million compared to the same period in 2024. The company’s profit also rose by 15.3%, driven by revenue growth and increased sales of products under the national volume-based procurement policy, highlighting its strengthened market position and operational performance.
The most recent analyst rating on (HK:1789) stock is a Buy with a HK$7.50 price target. To see the full list of analyst forecasts on AK Medical Holdings Ltd. stock, see the HK:1789 Stock Forecast page.
More about AK Medical Holdings Ltd.
AK Medical Holdings Ltd. is a company incorporated in the Cayman Islands, primarily engaged in the medical industry. The company focuses on the production and sale of surgical products, with a significant emphasis on leveraging volume-based procurement policies to enhance import substitution and meet growing demand.
Average Trading Volume: 6,122,306
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.5B
For an in-depth examination of 1789 stock, go to TipRanks’ Overview page.